Related Experiment Video
Updated: Jul 19, 2026
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 function
David A Schwarz1, Molly M Allen, Robert E Petroski
1Neurocrine Biosciences, Inc., Department of Molecular Biology, 12790 El Camino Real, San Diego, CA 92130, USA. dschwarz@neurocrine.com
Molecular and Cellular Endocrinology
|September 22, 2006
Summary
Novel benzopyridazinone antagonists show altered MCH-R1 inhibition rates. Modifications affect how quickly compounds inhibit receptor function, impacting biological responses in neurons.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- Melanin-concentrating hormone receptor 1 (MCH-R1) antagonists are investigated for therapeutic potential.
- Understanding antagonist kinetics is crucial for predicting in vivo efficacy.
Purpose of the Study:
- To investigate the inhibitory capacity of novel benzopyridazinone antagonists on MCH-R1 function.
- To determine the relationship between receptor affinity and functional inhibition over time.
- To explore the impact of receptor-antagonist interactions on neuronal signaling.
Main Methods:
- Synthesis and characterization of benzopyridazinone-based MCH-R1 antagonists.
- Measurement of receptor binding affinity and functional inhibition rates (on-rates).
- Site-directed mutagenesis of MCH-R1 to assess the role of specific amino acid residues (e.g., Phenylalanine 2.53).
- Electrophysiological recordings in cultured rat neurons to evaluate MCH-mediated calcium current inhibition.
Main Results:
- Three antagonists with similar MCH-R1 affinities exhibited significantly different functional inhibition rates.
- Chlorinated and trifluoromethyl-modified compounds displayed slow on-rates to maximal inhibition.
- Mutating MCH-R1 at position 2.53 (e.g., Phenylalanine to Alanine) altered the inhibitory kinetics of the chlorinated antagonist.
- Amino acid bulk at position 2.53 influenced antagonist efficacy, with smaller or similarly sized residues (Leucine, Tyrosine) showing wild-type-like phenotypes.
- In cultured neurons, the chlorinated antagonist showed reduced efficacy in reversing MCH-mediated calcium current inhibition.
Conclusions:
- Differential inhibitory on-rates of small-molecule antagonists significantly impact their ability to modulate receptor function.
- Antagonist kinetics, not just affinity, are critical determinants of biological response.
- Structural modifications of both antagonists and receptors can fine-tune inhibitory profiles.
Related Concept Videos
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...